---
layout: post
title: New Drug Approvals 2013 - Pt. XXIII Bazedoxifene (DUAVEE™)
date: '2014-01-22T18:09:00.000Z'
author: Grace Mugumbate
tags:
- Oral Drugs
- 2013 New Drugs
modified_time: '2014-03-08T20:06:58.575Z'
thumbnail: http://2.bp.blogspot.com/-PsgoqDvPhKA/Utlic3RAcLI/AAAAAAAAABo/5ttrWKr3z_Y/s72-c/bazedoxifene.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6510575125828153143
blogger_orig_url: http://chembl.blogspot.com/2014/01/new-drug-approvals-2013-pt-xxii_22.html
---

<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="margin-left: 1em; margin-right: 1em; text-align: center;">
<br /></div>
<div class="separator" style="margin-left: 1em; margin-right: 1em; text-align: center;">
<img border="0" height="41" src="https://www.ebi.ac.uk/chembltools/autoiconlarge2/1,0,0,2,0,1,0,0,0,1" width="400" /><span style="font-family: Times, 'Times New Roman', serif;">&nbsp; &nbsp;</span></div>
<div class="separator" style="margin-left: 1em; margin-right: 1em; text-align: center;">
<span style="font-family: Times, 'Times New Roman', serif;"><br /></span></div>
<div class="separator" style="margin-left: 1em; margin-right: 1em; text-align: center;">
<span style="font-family: Times, 'Times New Roman', serif;"><b>wikipedia:</b>&nbsp;<a href="http://en.wikipedia.org/wiki/Bazedoxifene">bazedoxifene</a> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></div>
<div style="text-align: left;">
<div style="text-align: center;">
<span style="font-family: Times, Times New Roman, serif; text-align: justify;"><b>ATC code:</b>&nbsp;</span><span style="background-color: white; color: #444444; font-family: arial, sans-serif; font-size: x-small; line-height: 16px;"><a href="http://www.whocc.no/atc_ddd_index/?code=G03XC02">G03XC02</a></span></div>
<span style="font-family: Times, Times New Roman, serif; text-align: justify;"><br /></span>
<span style="font-family: Arial, Helvetica, sans-serif;"><span style="text-align: justify;">On 3 October 2013, FDA approved&nbsp;</span><span style="text-align: justify;">a new drug,</span><span style="text-align: justify;">&nbsp;<a href="http://press.pfizer.com/press-release/pfizer-inc-announces-fda-approval-duavee-conjugated-estrogens-bazedoxifene-treatment-m">bazedoxifene</a> in combination with estrogen (trade&nbsp;name&nbsp;<a href="http://press.pfizer.com/press-release/pfizer-inc-announces-fda-approval-duavee-conjugated-estrogens-bazedoxifene-treatment-m">DUAVEE™</a>), for treatment of moderate-to-sever vasomotor symptoms (hot flashes) associated with menopause and the prevention of postmenopausal osteoporosis in women. Bazedoxifene reduces the risk of excessive growth of the uterus (endothermetrial hyperplasia) that can be caused by estrogen.</span></span></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; margin-left: 1em; margin-right: 1em;"><a href="http://2.bp.blogspot.com/-PsgoqDvPhKA/Utlic3RAcLI/AAAAAAAAABo/5ttrWKr3z_Y/s1600/bazedoxifene.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/-PsgoqDvPhKA/Utlic3RAcLI/AAAAAAAAABo/5ttrWKr3z_Y/s1600/bazedoxifene.png" height="320" width="240" /></a></span></div>
<div style="text-align: center;">
<div style="text-align: center;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif; text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><span style="text-align: left;">Bazedoxifene (IUPAC name: 1-{4-[2-(Azepan-1-yl)ethoxy]benzy}-2-(4-hydroxyphenyl}-3-methyl-1H-indole-5-ol)<span style="line-height: 21.112499237060547px;">&nbsp;is an&nbsp;</span></span><span style="text-align: left;">indole based small molecule of molecular weight of 470.6&nbsp;g/mol, polar surface area of 57.9, seven rotatable bonds, four hydrogen bond acceptors and one hydrogen bond donor. The compound is lipophilic with alogP 7.22, ApKa 10.12 and logD of 5.17.&nbsp;</span><span style="text-align: left;">The compound&nbsp;</span><span style="text-align: left;">is also known as WAY-140424, Bazedoxifene Acetate, Bazedoxifene, SID144206564, or SID124893775.</span></span></div>
</div>
</div>
<div style="text-align: left;">
<div>
</div>
</div>
<div style="text-align: left;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><br /></span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">Canonical Smiles:&nbsp;Cc1c(c2ccc(O)cc2)n(Cc3ccc(OCCN4CCCCCC4)cc3)c5ccc(O)cc15</span></div>
</div>
<div style="text-align: left;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">Standard InchI:&nbsp;<span style="font-size: x-small;">I</span>nChI=1S/C30H34N2O3/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31/h6-15,20,33-34H,2-5,16-19,21H2,1H3</span></div>
</div>
<div style="text-align: left;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><br />
</span></div>
</div>
<div style="text-align: left;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">Bazedoxifene is a <a href="http://en.wikipedia.org/wiki/Selective_estrogen-receptor_modulator">selective&nbsp;</a><a href="http://en.wikipedia.org/wiki/Selective_estrogen-receptor_modulator">estrogen receptor&nbsp;</a><a href="http://en.wikipedia.org/wiki/Selective_estrogen-receptor_modulator">&nbsp;modulator (SERM)</a> with a unique tissue and selectivity profile. <a href="http://en.wikipedia.org/wiki/Estrogen_receptor">Estrogen receptor</a>&nbsp;(PDBe:&nbsp;<a href="http://www.ebi.ac.uk/pdbe-srv/view/entry/4iwf/summary">4iwf</a>), is&nbsp;a transcription factor, which upon activation by a ligand, binds to DNA and regulates gene expression by mediating post-translational modification of histones and the associated transcriptional proteins.</span></div>
</div>
<div style="text-align: left;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><br />
 </span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-evPi0478RBE/Ut5bU9QOilI/AAAAAAAAACA/FXcMvoxgMVk/s1600/4iwf.png" imageanchor="1"><span style="font-family: Arial, Helvetica, sans-serif;"><img border="0" src="http://1.bp.blogspot.com/-evPi0478RBE/Ut5bU9QOilI/AAAAAAAAACA/FXcMvoxgMVk/s1600/4iwf.png" height="240" width="320" /></span></a></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></div>
</div>
<div style="text-align: left;">
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">Bazedoxifene is&nbsp;also known to prevent bone loss and osteoporotic fractures in postmenopausal women.&nbsp;&nbsp;The drug, comes in the form of a tablet containing&nbsp;0.45 mg estrogens and 20 mg bazedoxifene 20 mg. It is taken&nbsp;orally, once a day.&nbsp;Amongst other precautions, women taking DUAVEE should not take progestins, additional estrogens&nbsp;or additional estrogen agonist/antagonists. A detailed account of the prescribing information can be found <a href="http://labeling.pfizer.com/ShowLabeling.aspx?id=1174">here</a>.</span></div>
<span style="font-family: Arial, Helvetica, sans-serif;"><span style="text-align: justify;"><br /></span>
<span style="text-align: justify;">The license holders are Wyeth Pharmaceuticals, Inc. (a subsidiary of Pfizer Inc.,) based in Philadelphia, Pa.</span></span></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
